Hormonal contraception and breast cancer: the impact of formulation era, age, and ethnicity [0.03%]
激素避孕药与乳腺癌的关系：不同配方制剂、年龄和种族的影响
Ambrogio P Londero,Serena Bertozzi,Anjeza Xholli et al.
Ambrogio P Londero et al.
Oral contraceptives use and breast cancer risk: a systematic review and meta-analysis of prospective cohort studies [0.03%]
口服避孕药使用与乳腺癌风险的关系：前瞻性队列研究的系统评价和meta分析
Zhixing Zhao,Xiaoxiao Shi,Suna Liu et al.
Zhixing Zhao et al.
Objectives: Controversy persists regarding the association between oral contraceptives (OCs) use and breast cancer risk, with inconsistent findings from prior cohort studies. This study aimed to synthesise evidence on OCs...
High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment [0.03%]
2毫克地诺孕素抑制指数和转化指数高：进一步证明其可用于治疗子宫内膜异位症
Pedro Viana Pinto,Marta Barretta,Giovanni Grandi
Pedro Viana Pinto
Endometriosis is a common, chronic disease with a high burden for women, characterised by the implantation of endometrial cells outside the uterus. Many different treatments have been proposed for this disease, mainly hormonal, with the obj...
One-year clinical experience on the thromboembolic safety profile of the first prolonged release combined oral contraceptive containing 2 mg dienogest and 0.02 mg ethinyl-oestradiol [0.03%]
首个地诺孕素片联合口服避孕药(含2mg地诺孕素和0.02mg乙炔雌二醇)一年临床经验对血栓栓塞安全性评价
Giovanni Grandi,Inka Wiegratz,Alejandro Muñoz et al.
Giovanni Grandi et al.
Background: The introduction of a prolonged-release combined oral contraceptive (COC) with 2 mg dienogest (DNG) and 0.02 mg ethinyl-oestradiol (EE) in a 24/4 daily regimen in over 17 countries between 2024 and 2025 has be...
Contraception for adolescent and young women. A consensus conference results [0.03%]
青春期和年轻妇女的避孕问题——共识会议结果
Franca Fruzzetti,Angelo Cagnacci,Manuala Farris et al.
Franca Fruzzetti et al.
Objective: This consensus aimed to establish a consensus on hormonal contraception for adolescents and young women by synthesising current evidence and expert opinions, ultimately forming an evidence-based framework to gu...
Improving access to postpartum contraception - a review of global guidelines with ESCRH consensus recommendations for Europe [0.03%]
产后避孕获取途径的改善——全球指南回顾及欧洲ESCRH共识建议
T Bombas,S Cameron,M Farris et al.
T Bombas et al.
Contraceptive counselling should be an integral component of pregnancy care. The antenatal period represents a critical window of opportunity to discuss postpartum contraceptive options, enabling women to make informed reproductive health d...
Hypertension and smoking as contraindications to combined hormonal contraception but not to postmenopausal hormone therapy: but natural oestrogens (oestradiol and estetrol) are the same! [0.03%]
高血压和吸烟是复合激素避孕的禁忌证，但不是绝经后激素治疗的禁忌证：但是天然雌激素（雌二醇和依西美辛）却并非如此！
Giovanni Grandi,Jacques Bertold Evens Versailles
Giovanni Grandi
Family planning and contraception in women of reproductive age with systemic lupus erythematosus: a narrative review [0.03%]
系统性红斑狼疮患者生育年龄的避孕与计划生育：综述文章
Mayara de Almeida Pereira,Thelma Skare,Renato Nisihara
Mayara de Almeida Pereira
Purpose: Systemic lupus erythematosus primarily affects women of reproductive age and is associated with increased maternal and foetal risks. Effective family planning is essential to prevent unplanned pregnancies and opt...
From hesitancy to hope: charting India's path to widespread HPV immunisation [0.03%]
从犹豫到希望：绘制印度人乳头瘤病毒疫苗广泛接种之路
Gaurav Khastgir,Pradip Kumar Saha,Rashmi Bagga
Gaurav Khastgir
Background: Cervical cancer remains the leading gynaecological malignancy in India, with a disproportionate burden among underserved populations. Although HPV vaccines have been available since 2008, national coverage has...
Outcomes of medical abortion with an intrauterine device in situ: a retrospective review [0.03%]
带宫内节育器药物流产结局回顾性分析研究
Kiara Marsh,Sharon T Cameron
Kiara Marsh
Background: There is a lack of evidence on the outcomes of medical abortion with an intrauterine device (IUD) in situ. Guidelines recommend IUD removal prior to medical abortion, but retrieval is not always possible. This...